Project Grant HT94252410180
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$284K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
This $1,400,500.00 Project Grant was awarded on August 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute For Research (PAVIR), a nonprofit foundation. The funding will support PAVIR's research efforts over a 3-year period ending on August 14, 2026 to investigate the role of inflammatory astrocyte reactivity in mild traumatic brain injury. PAVIR has extensive experience conducting medical research...
The Defense Health Agency awarded a $923,000 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Palo Alto Veterans Institute for Research (Pavir) to support research on "Engagement of Veterans with Lung Cancer". The project, with a performance period from August 1, 2025 to July 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research focused on lung cancer. As...
The Defense Health Agency awarded a $524,664 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) through the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, which runs from December 1, 2024 to November 30, 2026, will fund research into the "Mechanisms of Irisin-Induced Cognitive Benefit in PD." DFCI, a prestigious non-profit cancer research center in Boston, will leverage its expertise in areas like oncology, immunology, and...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...
The Department of Defense's Defense Health Agency awarded a $1,999,583 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to IRR Inc., a for-profit organization located in Santa Barbara, CA. The purpose of this early-stage proof-of-concept study is to evaluate a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The grant period of performance runs from July 1, 2025 to June 30, 2027. The Military Medical Research and...
The federal Project Grant award of $5,954,349.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The award was made to Virginia Commonwealth University (VCU), which is collaborating with the Palo Alto Veterans Institute for Research (Pavir) and the Richmond Institute for...
This Project Grant award of $260,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute for Research (PAVIR) to study the application of electrical current for promoting lymphatic regeneration. The research will be conducted by PAVIR in collaboration with Stanford University as a sub-recipient. The project seeks to experimentally investigate the electrokinetics of collagen matrix materials and...
The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...